Immunogenicity and Safety of Meningococcal C Conjugate Vaccine in Children and Adolescents Infected and Uninfected with Human Immunodeficiency Virus in Rio de Janeiro, Brazil

BACKGROUND: We aimed to evaluate the Neisseria meningitidis C conjugated vaccine (MCC) seroconversion and adverse events (AE) in HIV-infected and uninfected children and adolescents in Rio de Janeiro, Brazil. METHODS: HIV-infected or uninfected subjects, 2–18 years old, with CD4+ T-lymphocyte cell (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Infect Dis J
Main Authors: Frota, Ana Cristina C., Milagres, Lucimar G., Harrison, Lee H, Ferreira, Bianca, Barreto, Daniela Menna, Pereira, Gisele S., Cruz, Aline C., Pereira-Manfro, Wania, de Oliveira, Ricardo Hugo, Abreu, Thalita F., Hofer, Cristina B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4454630/
https://ncbi.nlm.nih.gov/pubmed/25876102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000000630
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados